HIMS Hims & Hers Health Class A30.59-0.42 (-1.4%)
Bullish play with a target stock price of $31 or above
Strategy has +77% upside potential and 11% overvalued
Outlook is neutral, with stock confined to a span of ±9%
Strategy has +53% ROI potential and 10% overvalued